Faecal carriage of ESBL-producing enterobacteriaceae and carbapenem-resistant Gram-negative bacilli in community settings

Journal of Infection in Developing Countries

Volumn 7, Issue 8, 2013, Pages 630-634

  Villar, Hugo Edgardo ^a   Baserni, Marisa Noemí ^a   Jugo, Monica Beatriz ^a  

^a Laboratorio Hidalgo   (Argentina)

Author keywords

Carbapenemase; Extended spectrum lactamase; Faecal carriage; Multidrug resistant bacteria

Indexed keywords

CARBAPENEM; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN; CLAVULANIC ACID;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; CARBAPENEM RESISTANT GRAM NEGATIVE BACILLI; CHILD; DISEASE SURVEILLANCE; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; GRAM NEGATIVE BACTERIUM; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; PREVALENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ARGENTINA; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; CARRIER STATE; CEPHALOSPORINS; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; FECES; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PREVALENCE; YOUNG ADULT;

EID: 84881650473     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.2900     Document Type: Article

References (19)

1. Pitout JD and Laupland KB (2008) Extended-spectrum β- lactamase-producing Enterobacteriaceae: an emerging publichealth concern. Lancet Infect Dis 8: 159-166.
2. Walsh TR, Toleman MA, Poirel L, Nordmann P (2005) Metallo-β-lactamases: The quiet before the storm? Clin Microbiol Rev 18: 306-325.
3. Yong D, Toleman MA, Giske CG (2009) Characterization of a new metallo-β-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 53: 5046-5054.
4. Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, Alberti S, Bush K, Tenover FC (2001) Novel carbapenem-hydrolyzing b-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 45:1151-1161.
5. Gales AC, Castanheira M, Jones RN, Sader HS (2012) Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008- 2010) Diagn Microbiol Infect Dis. 73: 354-360.
6. Smith DL, Dushoff J, Perencevich EN, Harris AD, Levin SA (2004) Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: resistance is a regional problem. Proc Natl Acad Sci USA 101: 3709-3714.
7. Levin BR (2001) Minimizing potential resistance: a population dynamics view. Clin Infect Dis 33: S161-169.
8. Tschudin-Sutter S, Frei R, Battegay M, Hoesli I, Widmer AF. (2010) Extended-spectrum β-lactamase-producing Escherichia coli in neonatal care unit. Emerg Infect Dis. 16: 1758-1760.
9. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing. Nineteenth informational supplement, M100-S19. Clinical and Laboratory Standards Institute, Wayne, PA.
10. Castillo García FJ, Seral García C, Pardos De la Gándara M, Millán Lou MI, Pitart Ferré C(2007) Prevalence of fecal carriage of ESBL-producing Enterobacteriaceae in hospitalized and ambulatory patients during two non-outbreak periods. Eur J Clin Microbiol Infect Dis 26: 77-78.
11. Kader AA, Kumar A, Kamath KA.(2007) Fecal carriage of extended-spectrum b-lactamase-producing Escherichia coli and Klebsiella pneumoniae in patients and asymptomatic healthy individuals. Infect Control Hosp Epidemiol 28: 1114-1116.
12. Pallecchi L, Bartoloni A, Fiorelli C, Mantella A, Di Maggio T, Gamboa H, Gotuzzo E, Kronvall G, Paradisi F, Rossolini GM (2007) Rapid dissemination and diversity of CTX-M extended-spectrum b-lactamase genes in commensal Escherichia coli isolates from healthy children from lowresource settings in Latin America. Antimicrob Agents Chemother 51: 2720-2725.
13. Ben-Ami R, Schwaber MJ, Navon-Venezia S, Schwartz D, Giladi M, Chmelnitsky I, Leavitt A, Carmelli Y (2006) Influx of extended-spectrum b-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis 42: 925-934.
14. Valverde A, Coque TM, Sánchez-Moreno MP, Rollán A, Baquero F, Cantón R (2004) Dramatic increase in prevalence of fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J. Clin. Microbiol 42: 4769-4775.
15. Rodrigues CU, Shukla SJ, Mehta A (2005) Extendedspectrum β-lactamase producing flora in healthy persons. Emerging Infect Dis 11: 981-982.
16. Sasaki T, Hirai I, Niki M, Nakamura T, Komalami C, Maipanich W, Kusolsuc T, Sa-Nquankiat S, Pubampen S, Yamamoto Y (2010) High prevalence of CTX-M betalactamase-producing Enterobacteriaceae in stool specimens obtained from healthy individuals in Thailand. J Antimicrob Chemother 65: 666-668.
17. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, Caniça MM, Park YJ, Lavigne JP, Pitout J, Johnson JR (2008) Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 61: 273-281.
18. Oteo J, Pérez-Vázquez M, Campos J.(2010) Extendedspectrum betalactamase producing Escherichia coli: changing epidemiology and clinical impact. Curr Opin Infect Dis 23: 320-326.
19. Radice M, Power P, Gutkind G, Fernández K, Vay C, Famiglietti A, Ricover N, Ayala JA (2004) First class A carbapenemase isolated from Enterobacteriaceae in Argentina. Antimicrob Agents Chemother 48: 1068-1069.